Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,399 | -11,958 | -8,395 | -4,378 | -4,054 |
| Depreciation Amortization | 1,635 | 1,236 | 630 | 176 | 42 |
| Accounts receivable | -12 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -255 | 366 | -152 | -32 | -1,930 |
| Other Working Capital | -211 | -2,313 | -4,232 | -1,756 | 5,893 |
| Other Operating Activity | 2,357 | 1,339 | 1,261 | 520 | 5,522 |
| Operating Cash Flow | $-9,886 | $-11,330 | $-10,888 | $-5,471 | $5,474 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -385 | -179 | -4 | -157 | -573 |
| Investing Cash Flow | $-385 | $-179 | $-4 | $-157 | $-573 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 487 | 487 | N/A | N/A | 562 |
| Debt Repayment | -1,818 | -1,289 | -709 | -187 | -581 |
| Common Stock Issued | 20,930 | 19,655 | 911 | 434 | 454 |
| Other Financing Activity | -322 | 0 | 0 | 0 | -79 |
| Financing Cash Flow | $19,277 | $18,853 | $203 | $247 | $355 |
| Exchange Rate Effect | 7 | 33 | 26 | 13 | -68 |
| Beginning Cash Position | 15,998 | 15,998 | 15,998 | 15,998 | 10,811 |
| End Cash Position | 25,011 | 23,375 | 5,335 | 10,630 | 15,998 |
| Net Cash Flow | $9,013 | $7,377 | $-10,663 | $-5,368 | $5,187 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,886 | -11,330 | -10,888 | -5,471 | 5,474 |
| Capital Expenditure | -385 | -179 | -4 | -157 | -573 |
| Free Cash Flow | -10,271 | -11,509 | -10,892 | -5,628 | 4,901 |